139 related articles for article (PubMed ID: 36505291)
1. Meta-analysis of the effect and safety of recombinant human interferon α-2b combined with Baofukang suppository in the treatment of HPV infection.
He C; Song C; Li M; Ma W; Sun S
Am J Transl Res; 2022; 14(11):7632-7642. PubMed ID: 36505291
[TBL] [Abstract][Full Text] [Related]
2. Comparative Efficacy and Safety of Chinese Patent Medicines for Cervical High-risk Human Papillomavirus Infection: A Bayesian Network Meta-analysis.
Bin C; Zhong H; Mo J; Wang Z; Li M; Wei S
J Cancer; 2023; 14(12):2373-2385. PubMed ID: 37576405
[No Abstract] [Full Text] [Related]
3. Baofukang suppository promotes the repair of vaginal epithelial cells in response to Candida albicans.
Li T; Niu X; Zhang X; Wang S; Liu Z
AMB Express; 2016 Dec; 6(1):109. PubMed ID: 27830496
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of Simiao decoction in the treatment of cervical HPV infection: A systematic review and meta-analysis of randomized clinical trials.
Qiu L; Chen Y; Wang J; Yu L; Wu Q; Mo H
Heliyon; 2023 Nov; 9(11):e21840. PubMed ID: 38034746
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials.
Rambout L; Hopkins L; Hutton B; Fergusson D
CMAJ; 2007 Aug; 177(5):469-79. PubMed ID: 17671238
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of combined high-dose interferon and red light therapy for the treatment of human papillomavirus and associated vaginitis and cervicitis: A prospective and randomized clinical study.
Shi HJ; Song H; Zhao QY; Tao CX; Liu M; Zhu QQ
Medicine (Baltimore); 2018 Sep; 97(37):e12398. PubMed ID: 30213012
[TBL] [Abstract][Full Text] [Related]
7. A comparison of peginterferon α-2a and α-2b for treatment-naive patients with chronic hepatitis C virus: A meta-analysis of randomized trials.
Zhao S; Liu E; Chen P; Cheng D; Lu S; Yu Q; Wang Y; Wei K; Yang P
Clin Ther; 2010 Aug; 32(9):1565-77. PubMed ID: 20974315
[TBL] [Abstract][Full Text] [Related]
8. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
Shepherd J; Jones J; Takeda A; Davidson P; Price A
Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
[TBL] [Abstract][Full Text] [Related]
9. Effects of Tenofovir Combined with Recombinant Human Interferon
Zhang H; Xian J; Li Y; Xiao L; Wang L
Evid Based Complement Alternat Med; 2022; 2022():1889628. PubMed ID: 35815265
[TBL] [Abstract][Full Text] [Related]
10. [The efficacy of recombinant interferon -2b in the treat ment of male infertility caused by human papilloma- virus].
Ibishev KS; Magomedov GA; Riabenchenko NN; Mantsov AA
Urologiia; 2020 Nov; (5):61-66. PubMed ID: 33185349
[TBL] [Abstract][Full Text] [Related]
11. Treatment of subclinical intraurethral human papilloma virus infection with interferon alfa-2b.
Levine LA; Elterman L; Rukstalis DB
Urology; 1996 Apr; 47(4):553-7. PubMed ID: 8638367
[TBL] [Abstract][Full Text] [Related]
12. Airway clearance devices for cystic fibrosis: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(26):1-50. PubMed ID: 23074531
[TBL] [Abstract][Full Text] [Related]
13. Construction and in vivo
Liu H; Zhu J; Bao P; Ding Y; Shen Y; Webster TJ; Xu Y
Int J Nanomedicine; 2019; 14():5339-5353. PubMed ID: 31409991
[TBL] [Abstract][Full Text] [Related]
14. Detoxification therapy of traditional Chinese medicine for genital tract high-risk human papillomavirus infection: A systematic review and meta-analysis.
Luo M; Yu J; Zhu S; Huang L; Chen Y; Wei S
PLoS One; 2019; 14(3):e0213062. PubMed ID: 30822331
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus vaccination in women undergoing excisional treatment for cervical intraepithelial neoplasia and subsequent risk of recurrence: A systematic review and meta-analysis.
Eriksen DO; Jensen PT; Schroll JB; Hammer A
Acta Obstet Gynecol Scand; 2022 Jun; 101(6):597-607. PubMed ID: 35470865
[TBL] [Abstract][Full Text] [Related]
16. HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer.
Liu G; Sharma M; Tan N; Barnabas RV
AIDS; 2018 Mar; 32(6):795-808. PubMed ID: 29369827
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic phase antibody response to the human papillomavirus type 16 E2 protein is associated with successful treatment of genital HPV lesions with systemic interferon alpha-2b.
Stellato G; Paavonen J; Nieminen P; Hibma M; Vilja P; Lehtinen M
Clin Diagn Virol; 1997 Feb; 7(3):167-72. PubMed ID: 9126686
[TBL] [Abstract][Full Text] [Related]
19. Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test.
Kyrgiou M; Kalliala IE; Mitra A; Fotopoulou C; Ghaem-Maghami S; Martin-Hirsch PP; Cruickshank M; Arbyn M; Paraskevaidis E
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD009836. PubMed ID: 28125861
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
